Evidence map›Paper›PMID 38361922›Full record

ArticleFrontiers in immunology2024

Mechanisms by which Factor H protects

Smrithi S Menon, Galia Ramirez-Toloza, Keith L Wycoff, Sean Ehinger, Jutamas Shaughnessy, Sanjay Ram, Viviana P Ferreira

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Smrithi S MenonDepartment of Medical Microbiology and Immunology, University of Toledo College of Medicine and Life Sciences, Toledo, OH, United States.
Galia Ramirez-TolozaLaboratory of Parasitology, Department of Animal Preventive Medicine, Faculty of Veterinary Medicine and Livestock Sciences, University of Chile, Santiago, Chile.
Keith L WycoffPlanet Biotechnology, Inc., Hayward, CA, United States.
Sean EhingerDepartment of Medical Microbiology and Immunology, University of Toledo College of Medicine and Life Sciences, Toledo, OH, United States.
Jutamas ShaughnessyDivision of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA, United States.
Sanjay RamDivision of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA, United States.
Viviana P FerreiraDepartment of Medical Microbiology and Immunology, University of Toledo College of Medicine and Life Sciences, Toledo, OH, United States.
University of Toledo Medical Center · USUniversity of Massachusetts Chan Medical School · USPlanet Biotechnology (United States) · USUniversity of Chile · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chagas disease, a chronic disabling disease caused by the protozoan

Indexed as

Chagas DiseaseTrypanosoma cruziComplement Factor HHumansComplement Factor Halternative pathwayevasion strategyFactor HFactor H-related protein-5Trypanosoma cruzi

Identifiers

PMID38361922
PMCPMC10867245
OpenAlexW4391444135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.